NCT03048266View on ClinicalTrials.gov

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

RecruitingOBSERVATIONAL

Enrollment

629

Participants

Timeline

Start Date

November 5, 2015

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2026

Conditions

Multiple Endocrine Neoplasia

Trial Locations (1)

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER